Inhaled Insulin - ‘Transition’ Programme Put In Place, UK

Following talks with Diabetes UK, Pfizer has announced that it is putting in place an extended ‘transition’ programme to supply Exubera (inhaled insulin) for a up to 12 further months, depending on existing stock levels and expiry dates. [click link for full article]

More: continued here

Filed under: Diabetes on December 29th, 2007